New Activities
Therapy for Staphylococcus aureus ...
This webinar reviews current practices and ongoing controversies in the treatment of Staphylococcus aureus bacteremia, a common infection with a ...
WatchDiagnostic and therapeutics in S. ...
This webinar explores the rapidly evolving landscape of Staphylococcus aureus diagnostics and therapeutics, bringing together three complementary perspectives that span ...
WatchDisinformation in infectious diseases
A timely ISAC webinar examining how disinformation shapes infectious‑disease communication and public trust. Jon Roozenbeek and Eliot Higgins unpack ...
On demand coming soonEmerging antimicrobial therapies for ...
This webinar brings together leading experts from Japan and Australia to explore recent advances in antimicrobial therapy from clinical, translational, ...
On demandEpisode 4: Prof. Kurt Naber
In this episode, Ian Gould sits down with Professor Kurt Naber — urologist, antimicrobial‑research pioneer, and previous ISAC President &...
ListenHow to get your paper published in IJAA ...
This expert-led webinar, hosted by ISAC and Elsevier, offers practical insights into publishing high quality antimicrobial research.
WatchLiving legends in infectious diseases
Listen to episode 1 of ISAC's new celebrating the individuals whose work has shaped modern infectious diseases, antimicrobial stewardship, diagnostics ...
Listen
MDR Infections in Critically Ill Patients
Challenges and Perspectives on MDR Infections in Critically Ill Patients
23 June 2026 @ 14.00 - 16.00 CET
ESCMID Study Group for Infections in Critically Ill Patients (ESGCIP) / ISAC Working Group on Infections in the ICU and Sepsis
This joint webinar will explore key challenges in managing multidrug‑resistant (MDR) infections in critically ill patients. Topics include antimicrobial stewardship in both high‑ and low‑antimicrobial resistance settings, optimisation of antimicrobial pharmacokinetics/pharmacodynamics using therapeutic drug monitoring, continuous infusion and nebulized antibiotics, and effective infection prevention and control strategies for MDR pathogens.
Programme
• Matteo Bassetti (Italy): Implementation of AMS in high AMR prevalence settings
• Christian Eckmann (Germany): Implementation of AMS in low AMR prevalence settings
• Sonia Luque (Spain): Optimisation of antimicrobial PK/PD in MDR infections (TDM, continuous infusion, nebulized antibiotics)
• Emine Alp Mese (Turkiye): Infection prevention and control strategies for MDR pathogens
